BSE (formerly Bombay Stock Exchange) | Live Stock Market.

Mankind Pharma IPO Subscription Status (Bidding Detail) The Mankind Pharma IPO is subscribed 15.32 times on Apr 27, 2023 7:02:00 PM. The public issue subscribed 0.92 times in the retail category, 49.16 times in the QIB category, and 3.80 times in the NII category.

May 9, 2023 . . 2 Comments Mankind Pharma IPO Details: Mankind Pharma IPO date is fixed, the IPO is to hit the market on April 25 and will close on April 27. Mankind Pharma IPO to raise around ₹4326 crores via IPO that comprises fresh issue of ₹ [.] crores, and offer for sale up to 4326 crores of ₹1 each.

Mankind IPO GMP Today. Mankind Pharma’s shares are currently trading at a premium of a whopping Rs 108 or 10 per cent up in the grey market, over the upper band of Rs 1,080 a share. So, the shares in the grey market are currently trading at Rs 1,188 apiece, on May 8. It indicates that the company’s shares are expected to be listed at a good.

Introduction. The Mankind Pharma IPO will open on April 25 and close on April 27, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 4,326.36 crores through this public offering, consisting of 400 lakhs shares with a face value of ₹ 10 each, which will be issued at a price of ₹ 1026 to ₹ 1080 per share.

JPMorgan believes that India’s fourth-largest pharmaceutical company will continue to gain market share, driven by its strong product portfolio and large distribution network. Shares of Mankind Pharma, which listed in May, have risen over 40 percent from its IPO price of Rs 1,080. The stock hit a new high of Rs 1,544 in today's trading session.

MannKind Corporation Common Stock (MNKD) Nasdaq Listed 0 No Notifications Add to Watchlist Add to Portfolio Quotes Summary Feb 3, 2023 9:34 am 10:19 am 11:09 am 11:59 am 12:53 pm 1:41 pm 2:35.

Anuh Pharma Share Price Sector: Biotechnology & Drugs + Add to Watchlist Powered by 82.90 -0.47 (-0.56%) 1D 5D 1M 3M 6M 1Y 5Y MAX Price Range Today’s Low 82.4 Today’s High 83.96 52 Week Low.

PIRAMAL PHARMA LIMITED analysts consensus, targets, ratings and recommendations | Bombay Stock Exchange: 543635 | Bombay Stock Exchange

Sekhmet Pharmaventures has joined the race to acquire BSE-listed Glenmark Life Sciences (GLS) as promoter Glenn Saldanha is looking to reduce the company's debt load, The Economic Times (ET) reported on Monday. Ahmedabad-based Nirma Group is already in the fray. Glenmark Pharmaceuticals Ltd owns an 82.8 per cent stake in GLS.

Share Price Today: Check here live NSE/BSE today's stock price, intraday, monthly, yearly, share performance, returns, key metrics, financials, peer comparison, technicals, share holdings, mutual.

Gland Pharma Ltd Share Price Today - Get Gland Pharma Ltd Share price LIVE on NSE/BSE and Price Chart, News, Announcements, Company Profile, Financial Statements, Company Holdings, Forecasts, Annual Reports and more!